Ophthalmic solution recalled for lack of sterility assurance
Pharmacy Innovations recalls a polyhexamethylene biguanide eye-drop solution nationwide due to insanitary manufacturing conditions. No illnesses have been reported.
What this means for you
Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.
Our severity reasoning: This is an FDA Class II recall. While Class II recalls can be severe, this scores as High (3) because no hospitalization, serious injury, or illness reports are documented. Sterility assurance failures in ophthalmic solutions pose significant risk of ocular infection; however, without actual cases reported, the hazard remains theoretical per the rubric.
Plain-English summary
Pharmacy Innovations, located in Erie, Pennsylvania, is recalling a polyhexamethylene biguanide 0.2% ophthalmic solution (eye drops) in 10-ml dropper bottles with product code t20221025@32. The product was distributed nationwide and is available by prescription only.
An FDA inspection of the manufacturing facility discovered insanitary conditions that compromise the sterility assurance of the product. Ophthalmic solutions must be sterile to prevent microbial contamination, which could cause serious eye infections or other ocular complications.
This recall affects patients nationwide who received this medication from their pharmacies.
Patients currently using this medication should contact their pharmacy or healthcare provider immediately for guidance. Do not discontinue the medication without medical advice. Pharmacies should check whether their inventory is affected and provide patients with an alternative or replacement medication.
The recalled product
- Product
- POLYHEXAMETHYLENE BIGUANIDE 0.2MG/ML (0.2%) (10ML DROPTAINER) OPTH SOLUTION, Rx Only, Pharmacy Innovations, 2936 W 17th St., Erie, PA.
- Manufacturer
- Pharmacy Innovations
- Category
- Drug — Ophthalmic / Eye Drops
- Hazard
- lack-of-sterility
- infection-risk
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (1)
- t20221025@32
Distribution
Distributed nationwide across the United States.
Related recalls
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- ModerateFDA Recalls Pred Mild Ophthalmic Suspension Due to Failed Stability Specifications
FDA (Drugs) · 2026-06-03
- ModerateNicotine Transdermal System Patches Recalled for Oxidative Impurity Specification Failure
FDA (Drugs) · 2026-06-03
- HighLiraglutide Injection Recalled Due to Particulate Matter in Cartridges
FDA (Drugs) · 2026-05-27
- LowPrimidone Tablets Recalled for Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27